Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-039435
Filing Date
2025-02-27
Accepted
2025-02-27 17:27:48
Documents
18
Effectiveness Date
2025-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 d886657ds8.htm S-8 33455
2 EX-5.1 d886657dex51.htm EX-5.1 6502
3 EX-23.1 d886657dex231.htm EX-23.1 2638
4 EX-FILING FEES d886657dexfilingfees.htm   iXBRL EX-FILING FEES 29384
5 GRAPHIC g886657dsp1.jpg GRAPHIC 8936
6 GRAPHIC g886657dsp1a.jpg GRAPHIC 4119
7 GRAPHIC g886657dsp_8.jpg GRAPHIC 3575
  Complete submission text file 0001193125-25-039435.txt   238471

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT d886657dexfilingfees_htm.xml XML 10383
Mailing Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285381 | Film No.: 25681007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)